The broad objectives of the research proposed in this application are to understand at the cellular and molecular levels, the physiological actions of sex hormones on the mucosal immune system. These actions account for changes in humoral and cellular immunity and have clinical applications in the treatment of venereal diseases, autoimmune diseases, malignancy, infertility and fertility control. Studies will be undertaken to: (1) examine the regulation by sex hormones and antigens of immune cells in the female reproductive tract; (2) elucidate the role of selected cytokines in the response of the genital tract to antigens and identify the way in which they interact with sex hormones to influence mucosal immunity; (3) identify the mechanism(s) responsible for estradiol-regulated movement of IgA and IgG; and (4) study the role of sex hormones antigens and cytokines in regulating secretory component (SC) and IgA gene expression. (1) As shown in the P.I.'s laboratory, intrauterine, Peyer's patches and intraperitoneal immunization leads to pronounced genital tract IgA- and IgG-antibody responses. These studies indicate that female sex hormones play a central role in genital tract immune responses, which vary with hormone balance, immunization site and secretion analyzed. Effects of the sex hormones on the presence and function of T- and B-lymphocytes, monocytes/macrophages and dendritic cells in the genital tract will be determined both prior to and following antigen exposure. Since uterine cells express MHC class II molecules, we will establish whether uterine immune cells process and present antigen. Sites (uterus, lymph nodes, spleen) of antigen presentation to T-lymphocytes will be identified and the role of sex hormones in the regulation of these events will be determined. (2) Since cytokines are used by immune cells for communication, we will examine the role of selected cytokines in regulating genital tract antibody responses to antigen. Possible cytokine synthesis by immune cells in the genital tract will be investigated. As a part of these studies, we will determine whether cytokine production is regulated by sex hormones and antigen. (3) Because sex hormones and selected cytokines control IgA levels in genital tract secretions, we will define the mechanism(s) whereby sex hormones, IFN-gamma and the interleukins regulate IgA movement in the uterus. Uterine epithelial cells will be grown to confluence on permeable membranes. Sex hormones and cytokine control of IgA transport will be analyzed to determine immunoglobulin specificity, directional movement and rate of transport. Since IgG is also controlled by sex hormones, we will determine whether IgG movement is receptor mediated or due to fluid phase pinocytosis. (4) Secretory component, the receptor for polymeric IgA, is the cornerstone of the efferent arm of the mucosal immune system. By regulating SC production, sex hormones, antigen and IFN-gamma exercise precise control over the presence of IgA in genital tract secretions. To study the mechanism(s) of estrogen, antigen and cytokine action, SC mRNA and IgA mRNA levels will be measured in uterine and cervico-vaginal tissues. If SC and/or IgA mRNA is hormonally regulated, then synthesis of message will be analyzed. In situ hybridization studies will be carried out to identify cells in the reproductive tract that synthesize SC and IgA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI013541-21
Application #
2855917
Study Section
Reproductive Endocrinology Study Section (REN)
Program Officer
Ash-Shaheed, Belinda
Project Start
1985-09-30
Project End
2001-12-31
Budget Start
1999-01-01
Budget End
1999-12-31
Support Year
21
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Physiology
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Shen, Zheng; Fahey, John V; Bodwell, Jack E et al. (2014) Sex hormones regulate tenofovir-diphosphate in female reproductive tract cells in culture. PLoS One 9:e100863
Haddad, Severina N; Wira, Charles R (2014) Estradiol regulation of constitutive and keratinocyte growth factor-induced CCL20 and CXCL1 secretion by mouse uterine epithelial cells. Am J Reprod Immunol 72:34-44
Patel, Mickey V; Ghosh, Mimi; Fahey, John V et al. (2014) Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions. Am J Reprod Immunol 72:22-33
Rodriguez-Garcia, Marta; Biswas, Nabanita; Patel, Mickey V et al. (2013) Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection. PLoS One 8:e62069
Rodriguez-Garcia, Marta; Patel, Mickey V; Wira, Charles R (2013) Innate and adaptive anti-HIV immune responses in the female reproductive tract. J Reprod Immunol 97:74-84
Biswas, Nabanita; Rodriguez-Garcia, Marta; Crist, Sarah G et al. (2013) Effect of tenofovir on nucleotidases and cytokines in HIV-1 target cells. PLoS One 8:e78814
Patel, Mickey V; Fahey, John V; Rossoll, Richard M et al. (2013) Innate immunity in the vagina (part I): estradiol inhibits HBD2 and elafin secretion by human vaginal epithelial cells. Am J Reprod Immunol 69:463-74
Coleman, Kimberly D; Ghosh, Mimi; Crist, Sarah G et al. (2012) Modulation of hepatocyte growth factor secretion in human female reproductive tract stromal fibroblasts by poly (I:C) and estradiol. Am J Reprod Immunol 67:44-53
Lahey, Timothy; Ghosh, Mimi; Fahey, John V et al. (2012) Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract. PLoS One 7:e38100
Ochiel, Daniel O; Rossoll, Richard M; Schaefer, Todd M et al. (2012) Effect of oestradiol and pathogen-associated molecular patterns on class II-mediated antigen presentation and immunomodulatory molecule expression in the mouse female reproductive tract. Immunology 135:51-62

Showing the most recent 10 out of 19 publications